Who Should Read This Article?
- Researchers, university professionals, and research administrators interested in medical and life sciences funding and the systems that sustain scientific research.
- Professionals and readers interested in the history, investment strategies, governance, and social impact of philanthropic foundations.
- Individuals working in global health, science and technology policy, and the translation of research discoveries into real-world applications.
Executive Summary
- The Wellcome Trust was established in 1936 using the fortune of pharmaceutical entrepreneur Henry Wellcome. It has since become one of the world's largest foundations supporting medical research, life sciences, and global health.
- Its defining characteristic is a long-term investment model that allows it to provide sustained research funding without primarily relying on government budgets or external donations.
- As of September 2025, its investment portfolio was worth approximately £39.9 billion, while its charitable expenditure reached approximately £1.9 billion in the 2024/25 financial year.
- Alongside fundamental discovery research, Wellcome now prioritizes infectious disease, mental health, and climate and health, with an increasing emphasis on translating scientific discoveries into tangible improvements in human health.
- As it evolves from a research funder into a foundation seeking to drive broader societal change, Wellcome faces challenges including declining global research funding, research translation, geographic inequalities, advances in AI, and the long-term sustainability of its investment model.
1. What Is the Wellcome Trust?
The Wellcome Trust is an independent research foundation based in the United Kingdom.
Established in 1936 using the fortune left by the founder of a pharmaceutical company, it has grown into one of the world's largest foundations supporting medical research, life sciences, and global health.[1]
Its most distinctive feature is its evolution from an organization that reinvested pharmaceutical profits into medical research into an independent foundation that manages a substantial investment portfolio and uses its financial resources to support research.
Since 2020, Wellcome has increasingly focused on three major global challenges—infectious disease, mental health, and climate and health—while maintaining broad support for fundamental scientific research.
In 2026, Wellcome further clarified its strategy through 2032, emphasizing the translation of scientific discoveries into improvements in healthcare and public health, as well as the equitable distribution of research benefits.[4][5]
Key Facts About the Wellcome Trust
| Item | Details |
|---|---|
| Name | Wellcome Trust |
| Established | 1936 |
| Founder | Henry Wellcome |
| Headquarters | United Kingdom |
| Organizational form | Independent charitable foundation and registered charity |
| Main activities | Medical and life sciences research funding, research infrastructure development, international collaboration, policy engagement, and public dialogue |
| Investment portfolio | Approximately £39.9 billion (September 2025) |
| Annual charitable expenditure | Approximately £1.9 billion (2024/25 financial year) |
| Investment and spending commitment through 2032 | More than £16 billion over the ten years from 2022 to 2032 |
Sources: Wellcome's official website and Annual Report 2025.[2][3][4]
Five characteristics are particularly important to understanding the Wellcome Trust.
- A distinctive financial model: Wellcome primarily finances its activities through long-term investment management rather than relying on donations or government budgets.
- A balance between fundamental research and societal challenges: It supports investigator-driven scientific discovery while pursuing the practical application of research in selected priority areas.
- Activities beyond grantmaking: It helps shape the scientific research environment through major research institutions, international collaborations, policy engagement, and public dialogue.
- A commitment to global equity: While continuing to support the UK's research infrastructure, it is strengthening research capacity in Africa, South Asia, and Southeast Asia.
- A period of strategic transformation: Its major challenges include reductions in global research funding, translating research into practical outcomes, advances in AI, and balancing investment returns with sustainable spending.
2. The History of the Wellcome Trust
2.1. Henry Wellcome and the Pharmaceutical Business
The founder of the Wellcome Trust, Henry Wellcome (1853–1936), was an American-born pharmaceutical entrepreneur.
In 1880, he co-founded Burroughs Wellcome & Co. in the United Kingdom with Silas Burroughs.
The company expanded through innovations in pharmaceutical manufacturing, marketing methods, and investment in research and development.
Henry Wellcome decided to leave his company and wealth for charitable purposes so that medical research could continue to receive support after his death.
Following his death in 1936, the Wellcome Trust was established in accordance with his will.[1]
The foundation inherited the pharmaceutical company's entire shareholding, along with Wellcome's extensive collections relating to medicine and medical history.
These assets became the foundation of the organization's financial resources and research support activities, which continue today.
2.2. Timeline of the Wellcome Trust's Development
| Year or period | Major event | Significance |
|---|---|---|
| 1880 | Founding of Burroughs Wellcome & Co. | Wealth generated by the pharmaceutical business eventually became the foundation's financial base. |
| 1936 | Establishment of the Wellcome Trust | Under Henry Wellcome's will, the foundation inherited shares in the pharmaceutical company and collections relating to medical history. |
| From 1938 | Beginning of medical research funding | Wellcome supported malaria research and expanded funding for medical researchers, research facilities, and medical history, primarily in the UK. |
| 1986 | Public listing of Wellcome plc | The company was listed on the London Stock Exchange. Approximately 25% of its shares were sold, raising around £200 million and enabling investment diversification. |
| 1995 | Independence from the pharmaceutical business | Following Glaxo's acquisition of Wellcome plc, the Trust sold most of its remaining shares in the company. |
| 2000s | Expansion of major research infrastructure and international research | Wellcome increased support for genomics, major research facilities, collaborative projects, and international research networks. |
| 2020 | Major strategic shift | While maintaining support for discovery research, Wellcome increased its focus on infectious disease, mental health, and climate and health. Wellcome Leap was also established. |
| 2022 | Announcement of a £16 billion spending commitment | Wellcome announced plans to invest more than £16 billion in research and health-related activities between 2022 and 2032. |
| 2026 | Further development of the strategy through 2032 | Wellcome emphasized equitable access to research benefits, implementation, policy influence, and strengthening research capacity across regions. |
Sources: Wellcome's official history, annual reports, and 2026 strategy.[1][2][5]
The public listing of Wellcome plc took place in 1986, although some historical materials refer to 1985 in discussions of preparations and early share-sale arrangements.
2.3. The 1995 Turning Point: Becoming Independent of the Pharmaceutical Business
The year 1995 represents a particularly important turning point in the history of the Wellcome Trust.
Before this transition, the Trust secured funding for its charitable activities through its ownership of the pharmaceutical company.
However, following Glaxo's acquisition of Wellcome plc, the Trust sold most of its remaining shares and moved from directly owning a pharmaceutical business toward operating as an independent investment and research funding organization.[1]
This transformation enabled Wellcome to diversify its financial assets and reduce its dependence on the performance of a single pharmaceutical company.
As a result, the organization could establish a more diversified financial foundation for sustained research funding.
2.4. The Shift Since 2020: From Research Funding to Solving Societal Challenges
Since 2020, the Wellcome Trust has undertaken a major shift in its research funding strategy.
While maintaining support for fundamental discovery research, it has increased its focus on three challenges: infectious disease, mental health, and climate and health.
It also established Wellcome Leap to advance high-risk, high-impact research and development that can be difficult to support through conventional grantmaking mechanisms.
In 2022, Wellcome announced a commitment to spend more than £16 billion over the ten-year period ending in 2032.
Its 2026 strategy further strengthened the emphasis on societal outcomes, policy influence, and the practical implementation of research findings rather than focusing solely on providing research funding.[4][5]
2.5. Three Stages in the Wellcome Trust's Evolution
The organization's approximately 90-year history can be divided into three broad stages.
Stage 1 (1936–1980s): A foundation reinvesting pharmaceutical profits into research
During this period, Wellcome supported medical research and research facilities using financial resources derived from the pharmaceutical company.
Stage 2 (1986–2010s): A foundation expanding research funding through investment management
Wellcome reduced its direct dependence on the pharmaceutical business, increased its capacity for research funding through asset management, and helped develop large-scale research infrastructure.
Stage 3 (2020–present): A foundation influencing the systems needed to address global health challenges
In addition to funding research, Wellcome increasingly engages in international collaboration, policy development, and research translation to help establish the systems required for meaningful improvements in health.
This evolution illustrates how Wellcome has moved from being primarily a source of research funding toward becoming an organization that helps shape the relationship between scientific research and society.
3. Organizational Characteristics of the Wellcome Trust
3.1. A Distinctive Financial Model Designed for Long-Term Research Funding
One of the Wellcome Trust's most important characteristics is its ability to reinvest financial resources generated through long-term management of a substantial endowment into research activities.
The organization began with assets inherited from the pharmaceutical business in 1936 and subsequently developed a diversified investment portfolio through share sales and investment diversification.
Today, the portfolio includes publicly listed equities, private equity, venture capital, real estate, hedge funds, and other asset classes.[3]
This funding model can be understood through four stages.
- Assets inherited from the historical pharmaceutical business: The original bequest in 1936 was followed by share sales and diversification.
- Development of a long-term investment portfolio: By September 2025, the investment portfolio had reached approximately £39.9 billion.
- Investment returns and planned use of financial resources: Wellcome seeks to balance long-term financial sustainability with substantial charitable expenditure.
- Reinvestment in research: Funds support fundamental science, research talent, research infrastructure, priority health challenges, policy engagement, and implementation.
This financial model offers three major advantages.
First, it reduces dependence on government budget cycles and short-term policy changes.
Second, it enables funding for research that may take decades to produce meaningful results.
Third, it allows the foundation to support scientific risks that other funding organizations may be reluctant to undertake.
However, financial independence does not eliminate investment risk.
Changes in financial markets can affect the value of Wellcome's portfolio, making it necessary to maintain a balance between long-term spending commitments and investment performance.
Wellcome is also a registered charity in the United Kingdom, with governance and investment activities subject to oversight by its governing board and applicable legal requirements.[2][3]
3.2. Combining Fundamental Discovery Research with Challenge-Oriented Investment
Another important characteristic of the Wellcome Trust is its simultaneous support for curiosity-driven fundamental research and investments focused on clearly defined societal challenges.
These approaches can broadly be understood as "Discovery" and "Solutions."
| Aspect | Discovery | Solutions |
|---|---|---|
| Fundamental philosophy | Emphasizes the freedom and creativity of researchers. | Begins with specific health challenges and works backward from the outcomes needed. |
| Research areas | A broad range of life sciences, health sciences, and related fields | Selected major health challenges |
| Objectives | Creation of new knowledge and methods | Development and adoption of interventions |
| Time horizon | Accommodates long-term scientific outcomes. | Also considers changes achievable within approximately ten years. |
| Evaluation priorities | Scientific originality and research quality | Scientific results and contributions to improvements in health |
This dual approach is a defining feature of Wellcome.
Fundamental research can be valuable even when its eventual practical applications remain uncertain.
At the same time, major challenges such as infectious disease and climate change require research results to be translated into effective interventions and improvements in healthcare.
Wellcome supports these different forms of research within the same foundation, despite their different time horizons and evaluation criteria.[4][5]
3.3. Building Research Infrastructure Rather Than Simply Awarding Grants
The Wellcome Trust does more than provide grants to external researchers and research institutions.
It also supports major research institutions and programs that create shared infrastructure for scientific research.
Three examples illustrate this role.
Wellcome Sanger Institute
The Wellcome Sanger Institute is a globally recognized center for genomics research.
It provides infrastructure for large-scale DNA analysis, genetics, and disease research, including projects that may be difficult for individual university laboratories to undertake independently.
Wellcome Collection
Wellcome Collection is a museum and library in London dedicated to health, medicine, culture, and human experience.
Through exhibitions, access to historical materials, and public events, it encourages dialogue between science and society.
Wellcome Leap
Established in 2020, Wellcome Leap supports high-risk, high-impact research and development.
Its programs are designed around specific goals and timelines, making it possible to pursue ambitious research that may be difficult to fund through conventional grantmaking mechanisms.
Through these activities, Wellcome functions not only as a grantmaker but also as a builder of research ecosystems, connecting scientists, institutions, technologies, policymakers, and communities.[1][2][4]
4. Current Strategic Priorities
The Wellcome Trust currently focuses on four major research and health-related areas, including fundamental discovery research.
Together with Wellcome Collection, these constitute five major strategic programs.[2][4]
4.1. Discovery Research
Discovery Research supports a broad range of scientific investigations aimed at understanding the fundamental principles of life, health, and well-being.
Its scope extends from molecular and cellular research to relevant social sciences and humanities.
In addition to funding specific research topics, Wellcome places significant importance on the development of researchers' careers.
This area does not necessarily require immediate commercialization or practical implementation.
Instead, it emphasizes scientific originality and the generation of new knowledge and methods.
4.2. Infectious Disease
In infectious disease research, Wellcome supports the development of vaccines, therapeutics, approaches to antimicrobial resistance, and other research aimed at preventing and controlling infectious diseases.
A particularly important objective is ensuring that scientific advances reach people living in regions where the burden of infectious disease is greatest.
Effective infectious disease responses require not only the development of new treatments and vaccines but also systems that make these interventions available where they are needed.
Wellcome is increasingly emphasizing the connection between research and development and the practical delivery of its results.
4.3. Mental Health
In mental health, Wellcome prioritizes research into conditions including anxiety, depression, and psychotic disorders.
Its areas of interest include understanding underlying mechanisms, developing early interventions, and identifying more effective forms of treatment and support.
Strengthening scientific evidence relating to mental health symptoms is another important research objective.
Through advances in research, Wellcome aims to help deliver more appropriate care and treatment to people experiencing mental health conditions.
4.4. Climate and Health
The Climate and Health program examines how climate change affects human health and how societies can respond to these effects.
Research topics include extreme heat, air pollution, and changes in the geographic distribution of infectious diseases.
Wellcome supports scientific assessment of these health risks and the development of adaptation measures, while encouraging the use of scientific evidence in policy decisions.
The program is based on the recognition that climate change is not only an environmental issue but also a major health challenge.
It therefore emphasizes connecting scientific research with practical societal responses.
4.5. Wellcome Collection: Connecting Science, Culture, and Society
Wellcome Collection connects medicine and science with human experience.
Through exhibitions, access to collections, and public events, it encourages greater understanding of health and medicine and creates opportunities for dialogue across society.
An important characteristic of this work is that it seeks to make scientific knowledge meaningful and accessible beyond specialist research communities.
4.6. Shifting Geographic Priorities
While continuing to support the UK's research infrastructure, the Wellcome Trust is expanding its investments in research across Africa, South Asia, and Southeast Asia.
In June 2026, Wellcome set a target to direct at least 25% of its active research investment to Africa, South Asia, and Southeast Asia by 2030.[5]
This does not simply mean transferring research funding to lower-income countries.
It also involves enabling local researchers and institutions to define research priorities independently and translate findings into improvements in health within their own regions.
The shift can therefore be understood as a move toward strengthening research capacity and decision-making, rather than focusing exclusively on the geographic allocation of funding.
5. Financial Scale and Research Funding Activities
Wellcome's financial results for the 2024/25 financial year, ending September 30, 2025, were published in January 2026.
These figures provide a clearer understanding of the scale of its activities.[2]
5.1. Key Financial and Research Funding Indicators
| Indicator | 2024/25 financial year |
|---|---|
| Investment portfolio | £39.9 billion |
| Total funds after liabilities | £35.7 billion |
| Charitable expenditure | £1.916 billion |
| Investment return | 10.2% (in GBP) |
| Number of active research grants | 2,723 |
| Total value of active grants | £7.3 billion |
| Countries covered by research grants | 133 |
Source: Wellcome Annual Report 2025.[2]
The £7.3 billion total value of active grants represents commitments extending across multiple years, rather than spending within a single financial year.
5.2. Growth in Annual Charitable Expenditure
The Wellcome Trust has increased its annual charitable expenditure in recent years.
| Financial year | Charitable expenditure |
|---|---|
| 2023/24 | £1.577 billion |
| 2024/25 | £1.916 billion |
Charitable expenditure increased by approximately 21.5% in 2024/25 compared with the previous year.[2]
Against its commitment to spend more than £16 billion by 2032, cumulative expenditure since 2022 had reached approximately £5.2 billion by September 2025.
These figures demonstrate that Wellcome not only holds substantial financial assets but is also actively expanding its spending on research and health-related activities.
5.3. Long-Term Investment Returns and Financial Sustainability
Wellcome's investment strategy includes long-term financial objectives.
Its annual reporting describes an approach designed to preserve the portfolio's real value over time, with a target return of at least 4% per year after inflation.
However, its real annualized return over the preceding three years was 1.4%, below the long-term target over that shorter period.[2][3]
This is an important consideration when evaluating Wellcome's funding model.
Holding approximately £40 billion in assets does not mean that research expenditure can increase without limit.
To preserve the ability to support future generations of researchers, Wellcome must maintain an appropriate balance between spending, inflation, and investment returns.
In other words, it must reconcile ambitious investment in research with the long-term sustainability of the foundation itself.
6. Six Major Challenges Facing the Wellcome Trust
Wellcome's strategy through 2032, published in June 2026, acknowledges significant changes in the global research environment.[5]
Based on its strategy and annual reporting, six major challenges can be identified.
6.1. Challenge 1: Declining Global Funding for Research and International Health
The global research environment is being affected by reductions in national research and development budgets, cuts to international health assistance, financial pressures on UK universities, and the withdrawal of some pharmaceutical companies from certain global health activities.
In February 2025, Wellcome's CEO explained that reductions in US funding for international health and research were directly and indirectly affecting major research programs in Africa and Asia.
The CEO also expressed the view that private foundations would be unable to fully compensate for reductions in government funding.
The fundamental challenge is that Wellcome cannot sustain the global research and public health system on its own, even if it increases its own grantmaking.
It therefore needs to work with governments, companies, and other foundations to maximize the impact of limited financial resources.[5]
6.2. Challenge 2: Translating Research Results into Improvements in Health
There is often a substantial gap between supporting fundamental research and ensuring that its results are implemented in real healthcare settings.
For example, even when a new infectious disease treatment is developed, barriers involving price, regulatory approval, manufacturing capacity, distribution, and healthcare access can prevent it from reaching the people who need it most.
In its 2026 strategy, Wellcome emphasizes stronger connections not only with researchers but also with policymakers, healthcare systems, and local communities.[5]
The fundamental challenge is determining how to measure and achieve the actual contribution of research to better health, rather than defining research success solely through publications or the number of new technologies developed.
6.3. Challenge 3: Geographic Inequalities in Research Funding and Outcomes
The regions where research is most urgently needed are not necessarily the same regions where research funding, facilities, and scientific talent are concentrated.
Although Wellcome plans to expand research investments in Africa and Asia, the amount of funding alone is not the only consideration.
Other important questions include who defines research priorities, who owns and can use research outputs, and how local researchers can build sustainable careers.
Wellcome also acknowledges in its official history that Henry Wellcome's business activities were connected to British colonial policies and the medical knowledge of Indigenous peoples.
The organization has undertaken efforts to address issues involving the treatment of its historical collections.[1]
The underlying challenge is to move beyond traditionally Western-centered research funding structures toward systems in which local researchers and communities can lead research and benefit from its outcomes.
6.4. Challenge 4: Advances in AI and Data Science, and Trust in Science
Artificial intelligence and large-scale data analysis have the potential to transform drug discovery, genomics, diagnostics, and scientific productivity.
At the same time, these developments raise questions about the appropriate use of AI, equitable access to research data, scientific reliability, and public understanding of research.
In its 2026 strategy, Wellcome recognizes advances in data and AI as both opportunities and risks.
It also identifies declining trust in science and innovation as a challenge in the external environment.[5]
The central issue is how to take advantage of technological progress while avoiding a situation in which its benefits become concentrated in particular countries or organizations.
6.5. Challenge 5: Financial Sustainability and Ethical Investment
The Wellcome Trust relies on long-term investment management to sustain its research activities.
As research expenditure grows, uncertainty surrounding investment returns becomes increasingly important.
In addition, as a foundation supporting research on climate change, Wellcome faces expectations concerning the greenhouse gas emissions associated with its investment portfolio and the behavior of companies in which it invests.
Wellcome has committed to bringing its investment portfolio to net-zero emissions by 2050 at the latest and is pursuing responsible investment and engagement with companies.[3]
The core challenge is balancing three objectives: generating investment returns, preserving assets over the long term, and fulfilling social responsibilities.
6.6. Challenge 6: Evolving from a Research Funder into a Foundation Driving Societal Change
One of the most important aspects of Wellcome's 2026 strategy is its intention to expand its role beyond traditional research grantmaking.
Its future approach combines financial grants with international collaboration, policy influence, research implementation, and new approaches to providing capital.[5]
However, a broader organizational role also creates difficult questions.
Which activities should Wellcome prioritize?
Which responsibilities should be left to other institutions?
How should Wellcome measure its own contribution to broader societal outcomes?
The fundamental challenge is to retain its strengths and expertise as a research funder while taking on a wider role in addressing global health challenges.
6.7. Summary of Current Challenges
The six challenges can be summarized as follows.
| Challenge | Importance assessment | Potential response |
|---|---|---|
| Declining global research funding | High | Co-investment with governments and other foundations |
| Translating research into practice | High | Stronger connections with healthcare systems and policymakers |
| Geographic inequalities in research | High | Strengthening local researchers and research infrastructure |
| AI and trust in science | Medium to high | Balancing the use of data and AI with effective governance |
| Financial and investment sustainability | High | Long-term investment management and disciplined spending |
| Expansion of organizational responsibilities | High | Strategic prioritization and impact measurement |
The importance ratings are qualitative assessments made in this article based on Wellcome's 2026 strategy and annual reporting. They are not official ratings assigned by the Wellcome Trust.
A common theme across these challenges is that providing funding for research is no longer sufficient on its own.
Increasingly, Wellcome must also engage with the processes through which scientific findings become available and useful to society.
7. Future Directions and Implications
The Wellcome Trust's history and current strategy suggest three important directions for its future development.
7.1. Continuing to Invest in Scientific Research Itself
First, Wellcome intends to maintain support for curiosity-driven fundamental research and large-scale research infrastructure.
Scientific research that does not have an immediate practical application will remain a central part of its activities.
The knowledge generated by fundamental research does not always have an obvious use at the time of discovery.
Wellcome's ability to support such research over long periods is a major strength of its independent financial model.
7.2. Strengthening Its Influence on Global Health and Research Systems
Second, Wellcome is moving toward a more integrated approach to improving research funding, scientific environments, public policy, and implementation through collaboration with diverse partners.
Challenges such as infectious disease, mental health, and climate change cannot be resolved through individual scientific discoveries alone.
Scientific findings must be connected to improvements in institutions, healthcare systems, and local communities.
Wellcome is therefore expanding its involvement in the processes through which research results generate practical benefits for society.
7.3. Moving Toward a More Global Research and Decision-Making System
Third, Wellcome is moving away from a predominantly Western-centered research model toward a more globally distributed system of research and decision-making.
It aims to strengthen research infrastructure in Africa and Asia and increase the capacity of institutions in these regions to produce and use research findings.
This involves more than reallocating funding geographically.
It also means enabling local researchers and institutions to play a more influential role in determining research priorities, conducting research, and applying the results.[5]
8. What Can We Learn from the Wellcome Trust's Organizational Model?
The Wellcome Trust can be understood not merely as a foundation that funds medical research, but as an organization combining several distinct functions.
Four functions are particularly important.
8.1. Its Role as a Research Funder
Wellcome supports researchers and research institutions through large-scale, long-term grantmaking.
Its investment portfolio enables it to fund research without being driven primarily by short-term financial returns.
This capability is especially valuable in scientific fields where meaningful results may take many years to emerge.
8.2. Its Role as a Risk Taker
Through initiatives such as Wellcome Leap, the foundation supports high-risk, high-impact research and development that may be difficult to fund through conventional grantmaking.
Traditional research funding programs often place considerable weight on feasibility and the certainty of research plans.
By supporting more ambitious research, Wellcome helps explore new scientific and technological possibilities.
8.3. Its Role as a Builder of Research Infrastructure
Through support for institutions such as the Wellcome Sanger Institute, the foundation helps establish shared infrastructure that extends beyond individual researchers and laboratories.
By developing large-scale facilities, technologies, and research networks, Wellcome provides resources that can support a wide range of scientific activities.
8.4. Its Role as a Coordinator Across Society
Wellcome also engages in policy development, international collaboration, and public dialogue.
To ensure that scientific findings benefit society, collaboration is needed among research institutions, governments, businesses, healthcare providers, and citizens.
Wellcome plays a role in connecting these different stakeholders.
8.5. Summary of the Four Functions
| Function | Wellcome's activities | Implications for organizational models |
|---|---|---|
| Research funder | Large-scale, long-term research grants | Supporting research without dependence on short-term financial returns |
| Risk taker | Wellcome Leap and similar initiatives | Enabling ambitious projects that conventional research funding may not support |
| Research infrastructure builder | Wellcome Sanger Institute and other initiatives | Developing shared resources that extend beyond individual projects |
| Coordinator across society | Policy engagement, international collaboration, and public dialogue | Creating systems through which scientific discoveries can benefit society |
The Wellcome Trust's strength does not lie solely in the size of its financial assets.
It also lies in its ability to combine long-term investment in scientific research with mechanisms that help deliver the benefits of research to society.
Its 2026 strategy makes this direction particularly clear by placing greater emphasis on what research can change, rather than only on how much funding is invested.
9. Conclusion: What the Wellcome Trust's 90-Year History Reveals
The Wellcome Trust's development over approximately 90 years can be understood as an evolution from a mechanism for reinvesting pharmaceutical wealth into research to an independent scientific and philanthropic institution supporting solutions to global health challenges.
When it was established in 1936, its activities began with support for medical research using assets inherited from a pharmaceutical business.
During the 1980s and 1990s, it reduced its direct dependence on the pharmaceutical company and established a system for providing research funding through long-term asset management.
Since 2020, it has maintained support for fundamental research while increasing its focus on infectious disease, mental health, and climate and health.
Today, Wellcome is placing greater emphasis not only on financing research but also on shaping the systems that allow scientific discoveries to produce meaningful improvements in health.
Its greatest challenge going forward may not be simply expanding its assets or increasing the amount of funding it provides.
Rather, it is how to use its finite financial resources and organizational influence to ensure that research results contribute to equitable and sustainable improvements in health.
One particularly notable aspect of its approach is its attempt to maintain the freedom of fundamental research while simultaneously investing in research implementation and international scientific infrastructure.
These activities operate over different time horizons and require different approaches to assessing success.
The Wellcome Trust therefore offers an important example for considering the future roles of research funding organizations and philanthropic foundations focused on science and technology.
Beyond the scale of research funding, it raises broader questions.
How should societies create the environments needed to sustain scientific research?
Who should benefit from scientific discoveries?
And how can research findings be translated into meaningful improvements in people's lives?
The history and current strategy of the Wellcome Trust provide valuable perspectives for exploring these questions.
References
[1] Wellcome, "History of Wellcome," Wellcome official website. https://wellcome.org/about-us/history-wellcome
[2] Wellcome, "Wellcome Annual Report 2025," 2026. https://wellcome.org/insights/reports/wellcome-annual-report
[3] Wellcome, "Investments – How We Are Funded," Wellcome official website. https://wellcome.org/about-us/investments
[4] Wellcome, "Our Strategy," Wellcome official website. https://wellcome.org/our-priorities/strategy
[5] Wellcome, "Wellcome's Strategy to 2032," 2026. https://cms.wellcome.org/sites/default/files/2026-06/Wellcome%20strategy%20to%202032.pdf